
Meridian Bioscience VIVO
Quartalsbericht 2022-Q4
hinzugefügt 09.02.2023
Meridian Bioscience Langfristiger Schuldenstrom 2011-2026 | VIVO
Langfristiger Schuldenstrom Jährlich Meridian Bioscience
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.83 M | 1.99 M | 1.79 M | - | 5.25 M | 4.5 M | 3.75 M | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 5.25 M | 1.79 M | 3.18 M |
Langfristiger Schuldenstrom anderer Aktien in der Diagnostik & Forschung
| Name | Langfristiger Schuldenstrom | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
2.18 M | - | -6.23 % | $ 30.6 M | ||
|
Accelerate Diagnostics
AXDX
|
829 K | - | -61.36 % | $ 2.46 M | ||
|
Check-Cap Ltd.
CHEK
|
264 K | - | - | $ 9.42 M | ||
|
Aspira Women's Health
AWH
|
202 K | - | -6.19 % | $ 10.5 M | ||
|
Biocept
BIOC
|
518 K | - | -13.05 % | $ 7.29 M | ||
|
Chembio Diagnostics
CEMI
|
915 K | - | 0.22 % | $ 16.8 M | ||
|
DermTech
DMTK
|
3.07 M | - | -11.32 % | $ 2.94 M | ||
|
CareDx, Inc
CDNA
|
6.52 M | $ 22.42 | 27.6 % | $ 1.19 B | ||
|
Akumin
AKU
|
17.2 M | - | -17.87 % | $ 25.9 M | ||
|
Exact Sciences Corporation
EXAS
|
33.6 M | - | - | $ 19.8 B | ||
|
Enzo Biochem
ENZ
|
841 K | - | -8.98 % | $ 14.8 K | ||
|
Co-Diagnostics
CODX
|
662 K | $ 1.46 | 2.82 % | $ 1.94 M | ||
|
Castle Biosciences
CSTL
|
1.66 M | $ 24.56 | -0.24 % | $ 682 M | ||
|
Global Cord Blood Corporation
CO
|
147 K | - | - | $ 399 M | ||
|
Genetic Technologies Limited
GENE
|
264 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
21.5 M | - | 0.12 % | $ 80.1 M | ||
|
Charles River Laboratories International
CRL
|
57.7 M | $ 176.94 | -2.0 % | $ 8.77 B | ||
|
Medpace Holdings
MEDP
|
23.2 M | $ 515.65 | -0.56 % | $ 14.9 B | ||
|
Danaher Corporation
DHR
|
199 M | $ 193.78 | -2.18 % | $ 138 B | ||
|
Interpace Biosciences
IDXG
|
431 K | $ 2.2 | - | $ 9.73 M | ||
|
Heska Corporation
HSKA
|
2.94 M | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
475 K | - | -20.0 % | $ 1.06 M | ||
|
NeoGenomics
NEO
|
4.78 M | $ 8.16 | -5.99 % | $ 1.05 B | ||
|
Neogen Corporation
NEOG
|
5.64 M | $ 9.24 | -1.91 % | $ 2 B | ||
|
Illumina
ILMN
|
79 M | $ 132.72 | 0.35 % | $ 21.1 B | ||
|
Fulgent Genetics
FLGT
|
1.44 M | $ 16.13 | -0.25 % | $ 488 M | ||
|
Koninklijke Philips N.V.
PHG
|
241 M | $ 28.63 | -1.58 % | $ 20 B | ||
|
Guardant Health
GH
|
27.7 M | $ 85.7 | 0.99 % | $ 10.7 B | ||
|
QIAGEN N.V.
QGEN
|
23.4 M | - | - | $ 10.6 B | ||
|
Anixa Biosciences
ANIX
|
41 K | $ 2.83 | -3.41 % | $ 91.8 K | ||
|
Biomerica
BMRA
|
358 K | $ 2.2 | 4.27 % | $ 5.05 M | ||
|
Senseonics Holdings
SENS
|
496 K | $ 6.77 | -1.88 % | $ 282 M | ||
|
ICON Public Limited Company
ICLR
|
24.3 M | $ 115.58 | -0.79 % | $ 9.53 B | ||
|
Laboratory Corporation of America Holdings
LH
|
191 M | $ 266.36 | -0.14 % | $ 22.2 B | ||
|
Soleno Therapeutics
SLNO
|
726 K | $ 52.57 | - | $ 2.67 B | ||
|
Motus GI Holdings
MOTS
|
169 K | - | -34.28 % | $ 263 K | ||
|
Celcuity
CELC
|
54 K | $ 125.25 | 1.44 % | $ 5.86 B | ||
|
Neuronetics
STIM
|
5.56 M | $ 1.4 | 0.72 % | $ 92.3 M | ||
|
Myriad Genetics
MYGN
|
6.9 M | $ 5.0 | -3.66 % | $ 463 M | ||
|
Lantheus Holdings
LNTH
|
3.8 M | $ 83.92 | -0.02 % | $ 5.66 B | ||
|
Thermo Fisher Scientific
TMO
|
275 M | $ 516.0 | -2.95 % | $ 195 B | ||
|
Quest Diagnostics Incorporated
DGX
|
174 M | $ 191.46 | 0.02 % | $ 21.3 B | ||
|
ENDRA Life Sciences
NDRA
|
129 K | $ 5.17 | 0.58 % | $ 4.07 M | ||
|
Twist Bioscience Corporation
TWST
|
13.8 M | $ 56.23 | -2.41 % | $ 3.36 B |